AMMJ — American Cannabis Income Statement
0.000.00%
Last trade - 00:00
- $2.25m
- $2.94m
- $18.81m
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.982 | 2.13 | 1.57 | 2.43 | 18.8 |
Cost of Revenue | |||||
Gross Profit | 0.459 | 1.34 | 0.721 | 1.06 | 2.54 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1.71 | 2.15 | 2.19 | 3.82 | 19.4 |
Operating Profit | -0.725 | -0.02 | -0.624 | -1.4 | -0.606 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.951 | -0.302 | -0.532 | -1.44 | -0.633 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.951 | -0.302 | -0.532 | -1.44 | -0.633 |
Net Income Before Extraordinary Items | |||||
Net Income | -0.951 | -0.302 | -0.532 | -1.44 | -0.633 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.951 | -0.302 | -0.532 | -1.44 | -0.633 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.018 | -0.006 | -0.009 | -0.017 | -0.007 |